Interesting Articles

How Does Prognosis of NETs Differ Based on Site of Origin? by Dave Levitan

An analysis of more than 70,000 patients revealed significant differences with regard to survival between different sites of origin for neuroendocrine tumors (NETs). These differences could help guide therapy in these malignancies.

Click here to read the full article

Recent Publications in NET Research

Click here to view